United Health Products, Inc. announced that Quantum Health Group has advised UHP that it has filed an application to have HemoStyp qualify for class III use in general internal surgical procedures with the Ministry of Food and Drug Safety (MFDS) in South Korea. Quantum has further advised UHP that it anticipates a response within 70 days.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 USD | 0.00% |
|
+4.23% | -15.91% |
1st Jan change | Capi. | |
---|---|---|
-15.91% | 45.92M | |
+75.69% | 12.57B | |
-19.77% | 7.63B | |
-4.19% | 5.84B | |
+10.32% | 5.16B | |
-16.50% | 4.75B | |
-12.24% | 4.17B | |
+17.06% | 4.16B | |
-9.88% | 3.37B | |
+24.92% | 2.07B |
- Stock Market
- Equities
- UEEC Stock
- News United Health Products, Inc.
- United Health Products Issues Update on HemoStyp®South Korea MFDS Application